Millions of diabetics around the world take avandia, glaxo 's second - best - selling drug.
全球数百万的糖尿病患者服用文迪雅，文迪雅是葛兰素史克第二大畅销药物。
Shares of London-based Glaxo fell 57 cents to $39.46 in afternoon trading.
在下午的交易中，伦敦市场上葛兰素史克的股票下跌了57分至39.46美元。
Sirtris will remain an autonomous unit within Glaxo, with Dr. Westphal in charge.
SIRTRIS将会作为葛兰素的子公司在韦斯特·法尔博士的管理下保持自主经营。
Glaxo halted the trial "out of an abundance of caution" while it studies the data further, he said.
他还说，格兰素中止临床试验是“出于充分谨慎”，并仍在进一步研究试验数据。
Roche referred questions to GlaxoSmithKline. Glaxo representatives did not immediately return calls for comment Monday afternoon.
罗氏将相关问题交由葛兰素处理，而葛兰素史克的发言人在周一下午并没有立即对此发表评论。
Glaxo To Cut US Sales Reps For Avandia?
葛兰素可能削减美国的文迪雅销售代表？
Glaxo and senior FDA officials said other evidence conflicted with that finding.
葛兰素史克与FDA资深官员则声称另外的证据与此发现相左。
Glaxo based the price of Zantac on an assessment of its value to doctors and patients.
葛兰素是在评估了Zantac对医生和病人的价值后，确定它的价格的。
For many, including Rebecca Ray, IE manager at Glaxo inc., it is a step in the right direction.
许多人，包括格莱斯公司的工业工程经理瑞贝卡瑞都认为，这是正确方向上的一步。
"We take the allegations that have been raised very seriously," Glaxo said in a statement in response to the accusation.
葛兰素史克在声明中回应相关指控时指出：“我们非常严肃地对待这些指控。”
Glaxo shares rose 5.2 percent in extended U. S. trading to $52 from their close of $49.43 on the New York Stock Exchange.
葛兰素史克股票在美国延长交易时段上涨了5.2%，从纽约证券交易所收盘价$49.43上涨到$52。
As it turns out, Glaxo itself had already compiled a similar analysis that also found that the drug raised the risk of heart attacks.
而事实上，该公司自己也已经进行了类似分析，同样发现该药增加心梗的风险。
At London Stock Exchange, the sharp drop in the share price of Glaxo SmithKlein, the largest pharmaceutical company in Europe, has affected the market.
在伦敦股市，欧洲最大的制药企业葛兰素-史克公司的股票价格大幅下跌影响了股市行情。
Spokesmen for Merck and Glaxo say all indications are that their vaccines are safe and effective, and there is no evidence that a booster shot will be needed.
默克和葛兰素的发言人说所有证据表明疫苗是安全有效的。没有证据表明需要再加强注射一针。
Glaxo said Avandia was a valuable option because many patients need multiple drugs to keep blood sugar under control, and a portion of them cannot take some of the other therapies.
葛兰素史克称，文迪雅是一个有价值的选择，因为许多患者需要多样药物控制血糖，他们中的一部分不能采用其它治疗方案。
Glaxo said Avandia was a valuable option because many patients need multiple drugs to keep blood sugar under control, and a portion of them cannot take some of the other therapies.
葛兰素史克称，文迪雅是一个有价值的选择，因为许多患者需要多样药物控制血糖，他们中的一部分不能采用其它治疗方案。
应用推荐